Extracellular HSPA1A promotes the growth of hepatocarcinoma by augmenting tumor cell proliferation and apoptosis-resistance
Introduction
The development of a tumor could lead to reciprocal alternations in the host and the tumor. In tumor microenvironment, the death of cells due to metabolic, genotoxic, or anoxic stress results in the releasing of intracellular molecules. Besides these, cellular stress, damage, and inflammation also cause the releasing of intracellular molecules from cells. Some of these molecules are inflammatory mediators and are referred to as damage-associated molecular pattern (DAMP) molecules [1]. DAMP molecules play critical roles in triggering immune responses and activating repair mechanism so to produce both antitumor and protumor effects [1]. In tumor progression, the presence of necrosis in tumor is almost always deemed as a poor prognostic indicator [2], [3], [4], [5] by clinical observations, implying that the protumor effect of DAMP molecules might predominant in the process of tumor development.
What DAMP molecules are has been a matter of conjecture for a decade. In recent years, several candidates have been revealed, among which HSP72 is included [6]. The stress-inducible HSP70 in the cells functions as a cytoprotective protein when cells are exposed to stressful stimuli. The tumorigenic role of stress-inducible HSP70 in cells has been associated to its ability to maintain cell survival [7]. However, stress-inducible HSP70 can also be passively released from necrotic cells [8] as well as actively released when tumor cells are suffered from exogenous stress [9]. The HSP70 family consists of several highly homologous members. HSPA1A (originally name as HSP70-1, HSP72, HSPA1) is a stress-inducible member of HSP70 family [10]. Extracellular HSPA1A has been found to bind to Toll-like receptors (TLRs) 2 and 4 on antigen-presenting cells, NK cells, and B cells, and therefore exerts immunoregulatory effects [11]. Therefore, HSPA1A may have the potential utilization in anticancer therapeutical approaches based on its immunological role. On the other hand, however, TLR2 and TLR4 are expressed not only on immune cells but also on tumor cells [12]. TLR4 on tumor cells plays important roles in tumor progression, one of which is that TLR4 signaling may allow tumor cells to negatively regulate immune system for their own survival and growth [13]. Several studies have demonstrated that activation of TLR4 and TLR2 signaling in tumor cells by pathogen-associated molecular pattern (PAMP) molecules such as lipopolysaccharide (LPS) and zymosan A can dampen the anti-tumor functions of infiltrating immune cells or elicit a direct effect on tumor cells, thereby facilitating tumor outgrowth [14], [15], [16]. However, it is still not clear whether extracellular HSPA1A, as a potential ligand of TLR2 and TLR4, may promote tumor progression by directly affecting tumor cells.
In this study, we focus on the direct effect of extracellular HSPA1A (eHSPA1A) on tumor cells. Our data showed that eHSPA1A promoted tumor cell proliferation by activating NF-κB via TLR signaling pathway. eHSPA1A also promoted the expression of TLR4 in tumor cells and the release of HMGB1 from tumor cells, resulting in a long-lasting effect of TLR4 signaling. The tumor-promoting effect was still existent after the removal of HSPA1A.
Section snippets
Animals and cells
BALB/c mice (6–8-week-old) were purchased from Center of Medical Experimental Animals of Hubei Province (Wuhan, China). BALB/c athymic nude (nu/nu) mice (6–8 weeks old) were purchased from SLAC Laboratory Animal Co. Ltd. (Shanghai, China). The mice were maintained in the accredited animal facility of Tongji Medical College, and used for studies approved by the Animal Care and Use Committee of Tongji Medical College. Murine H22, human BEL-7402, and human HepG2 hepatocarcinoma cell lines were
eHSPA1A has different effect on tumor growth in different stage of tumor progression
To investigate the effect of extracellular HSPA1A (eHSPA1A) on tumor growth, we first detected extracellular HSP70 (eHSP70) in tumor tissue using HSP70 antibody which detects HSPA1A and HSPA1L. As shown in Fig. 1a, eHSP70 was detectable in the tissue at site of tumor cell inoculation, and increased in local tissue along with the development of tumor. To verify the existence of eHSP70 in different types of tumors, we analyzed periphery tumor tissues from cancer patients. eHSP70 was detected in
Discussion
In this report, we provide evidence that extracellular HSPA1A can facilitate tumor growth by promoting proliferation and apoptosis-resistance of tumor cells. Stress-inducible HSP70 is abundantly expressed in various types of tumor cells, and regarded as a cancer relevant survival protein [26]. Once released into the extracellular milieu, HSPA1A could be an immunostimulatory factor which might stimulate antitumor immune response [11], [27]. Nevertheless, our data in this study showed a distinct
Conflict of interest statement
The authors declare no conflict of interest.
Acknowledgements
This work was supported by National Science Foundation of China (Nos. 30830095, 30771974, 30772589), Science Foundation of Ministry of Education of China (No. 20070487004), and National Development Program (973) For Key Basic Research of China (No. 2009CB521806).
References (37)
- et al.
Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer
Neoplasia
(2009) - et al.
Tumor necrosis correlates with angiogenesis and is a predictor of poor prognosis in malignant mesothelioma
Chest
(2003) - et al.
Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma
Int. J. Radiat. Oncol. Biol. Phys.
(2003) - et al.
Guidelines for the nomenclature of the human heat shock proteins
Cell Stress Chaperones
(2009) - et al.
Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4
Cancer Lett.
(2006) - et al.
Triptolide (PG-490) induces apoptosis of dendritic cells through sequential p38 MAP kinase phosphorylation and caspase 3 activation
Biochem. Biophys. Res. Commun.
(2004) - et al.
SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment
Blood
(2008) - et al.
Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4
J. Biol. Chem.
(2002) Toll-like receptors, inflammation and cancer
Semin. Cancer Biol.
(2006)- et al.
Necrosis and hypoxia in invasive breast carcinoma
Breast Cancer Res. Treat.
(2003)
Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis
Br. J Cancer
Extracellular Hsp72, an endogenous DAMP, is released by virally infected airway epithelial cells and activates neutrophils via Toll-like receptor (TLR)-4
Respir. Res.
Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy
J. Leukoc. Biol.
Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway
Int. Immunol.
Alternative mechanism by which IFN-gamma enhances tumor recognition: active release of heat shock protein 72
J. Immunol.
Initiation of the immune response by extracellular Hsp72: chaperokine activity of Hsp72
Curr. Immunol. Rev.
Cancer cells expressing Toll-like receptors and the tumor microenvironment
Cancer Microenviron.
TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer
Cancer Res.
Cited by (47)
Decoding the roles of heat shock proteins in liver cancer
2024, Cytokine and Growth Factor ReviewsTLR2/4 ligand-amplified liver inflammation promotes initiation of autoimmune hepatitis due to sustained IL-6/IL-12/IL-4/IL-25 expression
2018, Molecular ImmunologyCitation Excerpt :CCl4 was purchased from aladdin Biochemical Technology Co., Ltd (Shanghai, China). Plasmids pCYP2D6, pIL6, pIL12, psTLR2 and psTLR4 are expression vectors (pcDNA3.1, Invitrogen, Carlsbad, CA) carrying the cDNA encoding human CYP2D6, murine IL-6, murine IL-12, the extracellular domain of murine TLR2 and TLR4, respectively, which were constructed in our laboratory (Li et al., 2017; Yan et al., 2013; Liu et al., 2010; Wu et al., 2012). For in vivo gene transfection, plasmids were prepared and analyzed as described previously (Geng et al., 2006).
Sex difference in the heat shock response to high external load resistance training in older humans
2017, Experimental GerontologyCitation Excerpt :Though basically intracellular proteins, a great variety of stimuli have been reported to prompt Hsp70 release from living cells, including exercise and inflammatory cytokines (Walsh et al., 2001; Barreto et al., 2003). Wu and colleagues showed that extracellular Hsp70 (eHsp70) can promote tumor cell proliferation and resistance to apoptosis (Wu et al., 2012). Moreover, the presence of Hsp70 in the extracellular milieu has often been associated with a poor prognosis of disease (Pockley et al., 2003).
A novel quinazoline-based analog induces G2/M cell cycle arrest and apoptosis in human A549 lung cancer cells via a ROS-dependent mechanism
2017, Biochemical and Biophysical Research CommunicationsCitation Excerpt :In this study, our interest was focused on 6-amino-4-(4-phenoxyphenylethylamino)quinazoline (QNZ), a quinazoline-containing compound, known for its excellent NF-κB inhibitory activity [14]. Additionally, QNZ also exhibits as a novel anti-cancer reagent [15]. However, the action mechanisms behind are still unclear, and there is as yet scarcely any research related to designing QNZ-inspired anticancer agents based on the ROS-promoting strategy.
The Role of Extracellular Heat Shock Proteins in Cardiovascular Diseases
2023, Biomedicines